Orthometrix Stock

Orthometrix ROCE

The Return on Capital Employed (ROCE) of Orthometrix (OMRX) as of Aug 4, 2026 is -4.66 %.

ROCE

-4.66 %

Last updated:

In 2026, Orthometrix's return on capital employed (ROCE) was -4.66 %, a % increase from the - ROCE in the previous year.

Access this data via the Eulerpool API

Orthometrix Stock analysis

What does Orthometrix do? Orthometrix Inc is a leading provider of medical devices and services in the field of orthopedics. The company was founded in 1986 and is headquartered in White Plains, New York. Orthometrix operates various business segments, including the development and manufacturing of medical devices, as well as the provision of services related to orthopedic conditions. Orthometrix's business model is based on the development and manufacturing of medical devices that help diagnose and treat orthopedic conditions. In addition, the company also offers services related to orthopedic conditions, such as posture and gait analysis. The different divisions of Orthometrix include diagnostics, rehabilitation, and medical devices. In the diagnostics area, Orthometrix offers a range of products that help diagnose orthopedic conditions. These include electromyography systems, which measure the electrical activity of muscles, as well as motion analysis systems that analyze posture, gait, and muscle function. In the rehabilitation area, Orthometrix offers a wide range of products that help rehabilitate the musculoskeletal system. These include weights and bands that can improve muscle training, as well as biofeedback systems that provide feedback on muscle activity. In the medical devices area, Orthometrix offers a range of devices that can be used to treat orthopedic conditions. These include knee braces that help improve knee protection, as well as hand and elbow braces that can be used to stabilize the wrist and elbow. Orthometrix has also specialized in providing services related to orthopedic conditions. This includes posture and gait analysis, which can help diagnose and treat orthopedic problems. Orthometrix also offers training and continuing education for medical professionals to ensure they are up to date with developments in the field of orthopedics. Overall, Orthometrix has achieved a leading position in the orthopedics field and is an important provider of medical devices and services for healthcare professionals and patients worldwide. With a wide range of products and services, Orthometrix has successfully established itself in the market and will continue to grow. Orthometrix is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Orthometrix's Return on Capital Employed (ROCE)

Orthometrix's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Orthometrix's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Orthometrix's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Orthometrix’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Orthometrix stock

Return on Capital Employed (ROCE) of Orthometrix is -4.66 % in 2026.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Orthometrix since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Orthometrix with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

Profitability — Orthometrix

All Key Metrics — Orthometrix